Human Anti-Human Igg1 Fc Antibody

Lab Reagents

Human Antibody Laboratories manufactures the human anti-human igg1 fc antibody reagents distributed by Genprice. The Human Anti-Human Igg1 Fc Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact human Antibody. Other Human products are available in stock. Specificity: Human Category: Anti-Human Group: Igg1 Fc

Igg1 Fc information

Mouse Monoclonal Anti-Human IgG1 (Fc-region)-AP conjugate

10121-AP 0.5 ml
EUR 270

Mouse Monoclonal Anti-Human IgG1 (Fc-region)-Biotin conjugate

10121-BT 0.5 ml
EUR 242.4

Mouse Monoclonal Anti-Human IgG1 (Fc-region)-FITC conjugate

10121-FITC 0.5 ml
EUR 270

Recombinant (HEK) Mouse IgG1-Fc (98-321aa, 102Cys/Ser, ~32 kda, His-tag, >95%, low endotoxin)

20102-101-FC 50
EUR 343.2

Recombinant Mouse IgG1 Fc

CX85-10ug 10ug
EUR 96
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse IgG1 Fc

CX85-1mg 1mg
EUR 850.8
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse IgG1 Fc

CX85-500ug 500ug
EUR 613.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse IgG1 Fc

CX85-50ug 50ug
EUR 169.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

IgG1 Fc Recombinant Protein

91-953 0.05 mg
EUR 764.7
Description: As a monomeric immunoglobulin that is predominately involved in the secondary antibody response and the only isotype that can pass through the human placenta, Immunoglobulin G (IgG) is synthesized and secreted by plasma B cells, and constitutes 75% of serum immunoglobulins in humans. IgG antibodies protect the body against the pathogens by agglutination and immobilization, complement activation, toxin neutralization, as well as the antibody-dependent cell-mediated cytotoxicity (ADCC). IgG tetramer contains two heavy chains (50 kDa ) and two light chains (25 kDa) linked by disulfide bonds, that is the two identical halves form the Y-like shape. IgG is digested by pepsin proteolysis into Fab fragment (antigen-binding fragment) and Fc fragment ("crystallizable" fragment). IgG1 is most abundant in serum among the four IgG subclasses (IgG1, 2, 3 and 4) and binds to Fc receptors (Fc gamma R ) on phagocytic cells with high affinity.

IgG1 Fc Recombinant Protein

91-956 0.05 mg
EUR 764.7
Description: As a monomeric immunoglobulin that is predominately involved in the secondary antibody response and the only isotype that can pass through the human placenta, Immunoglobulin G (IgG) is synthesized and secreted by plasma B cells. IgG antibodies protect the body against the pathogens by agglutination and immobilization, complement activation, toxin neutralization, as well as the antibody-dependent cell-mediated cytotoxicity (ADCC). IgG tetramer contains two heavy chains (50 kDa ) and two light chains (25 kDa) linked by disulfide bonds, that is the two identical halves form the Y-like shape. IgG is digested by pepsin proteolysis into Fab fragment (antigen-binding fragment) and Fc fragment ("crystallizable" fragment). IgG1 is most abundant in serum among the four IgG subclasses (IgG1, 2, 3 and 4) and binds to Fc receptors (Fc gamma R ) on phagocytic cells with high affinity.

IgG1 Fc Recombinant Protein

11-265 0.5 mg
EUR 1023
Description: Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). IgG1 Fc was reported has a novel role as a potential anti-inflammatory drug for treatment of human autoimmune diseases.

IgG1 Fc Recombinant Protein

11-266 0.5 mg
EUR 1023
Description: Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). IgG1 Fc was reported has a novel role as a potential anti-inflammatory drug for treatment of human autoimmune diseases.

IgG1 Fc Recombinant Protein

96-306 0.2 mg
EUR 619.8
Description: Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). IgG1 Fc was reported has a novel role as a potential anti-inflammatory drug for treatment of human autoimmune diseases.

IL6R, Fc-Fusion (IgG1)

100916-1 100 µg
EUR 320
Description: Human IL-6 Receptor, Genbank # NM_000565, a.a. 20-365 with C-terminal fusion to human IgG1 Fc region, expressed in HEK293 cells. MW = 65 kDa + glycans.

IL6R, Fc-Fusion (IgG1)

100916-2 1 mg
EUR 2720
Description: Human IL-6 Receptor, Genbank # NM_000565, a.a. 20-365 with C-terminal fusion to human IgG1 Fc region, expressed in HEK293 cells. MW = 65 kDa + glycans.

Rabbit Polyclonal antibody Anti-CRBN

Anti-CRBN 50 µg
EUR 418.8

RANK, Fc fusion (IgG1), Biotin Labeled (Human)

70822-1 25 µg
EUR 295
Description: Human Receptor Activator of Nuclear FactorκB (RANK), also known as TRANCE Receptor and TNFRSF11A, (Genbank Accession No. NM_003839), a.a. 30-212, fused at the C-terminus to the Fc portion of human IgG1, with a C-terminal Avi-tag, expressed in a HEK293 cell expression system. This protein is enzymatically biotinylated using AviTag™ technology. MW = 49 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation